Galina Wirth
Vieraileva tutkija
galina.wirth@uef.fi
Tutkimusryhmät
Julkaisut
13/13 kappaletta-
Capillary Dynamics Regulate Post-Ischemic Muscle Damage and Regeneration in Experimental Hindlimb Ischemia
Wirth, Galina; Juusola, Greta; Tarvainen, Santeri; Laakkonen, Johanna P.; Korpisalo, Petra; Ylä-Herttuala, Seppo. 2023. Cells. 12: -
Critical limb-threatening ischemia and microvascular transformation: clinical implications
Tarvainen, Santeri; Wirth, Galina; Juusola, Greta; Hautero, Olli; Kalliokoski, Kari; Sjöros, Tanja; Nikulainen, Veikko; Taavitsainen, Jouni; Hytönen, Jarkko; Frimodig, Crister; Happonen, Krista; Selander, Tuomas; Laitinen, Tomi; Hakovirta, Harri H; Knuuti, Juhani; Laham-Karam, Nihay; Hartikainen, Juha; Mäkinen, Kimmo; Ylä-Herttuala, Seppo; Korpisalo, Petra. 2023. European heart journal. 2024; 45: 255-264 -
EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF
Groppa, E; Brkic, S; Uccelli, A; Wirth, G; Korpisalo-Pirinen, P; Filippova, M; Dasen. B; Sacchi, V; Muraro, MG; Trani, M; Reginato, S; Gianni-Barrera, R; Ylä-Herttuala, S; Banfi, A. 2018. Embo reports. 19: e45054 -
T-2, T-1rho and T-RAFF4 detect early regenerative changes in mouse ischemic skeletal muscle
Laakso, Hanne; Wirth, Galina; Korpisalo, Petra; Ylä-Herttuala, Elias; Michaeli, Shalom; Ylä-Herttuala, Seppo; Liimatainen, Timo. 2018. Nmr in biomedicine. 31: e3909 -
Temporal Dynamics of Gene Expression During Endothelial Cell Differentiation From Human iPS Cells: A Comparison Study of Signalling Factors and Small Molecules
Belt, H; Koponen, JK; Kekarainen, T; Puttonen, KA; Mäkinen, PI; Niskanen, H;, Oja, J; Wirth, G; Koistinaho, J; Kaikkonen, MU; Ylä-Herttuala, S. 2018. Frontiers in cardiovascular medicine. 5: 16 -
Tomato thymidine kinase-based suicide gene therapy for malignant glioma - an alternative for Herpes Simplex virus-1 thymidine kinase
Stedt H, Samaranayake H, Kurkipuro J, Wirth G, Christiansen LS, Vuorio T, Määttä A-M, Pi¨kur J, Ylä-Herttuala S. 2015. Cancer gene therapy. 22: 130-137 -
Epigenetic upregulation of endogenous VEGF-A reduces myocardial infarct size in mice
Turunen Mikko P, Husso Tiia, Musthafa Haja, Laidinen Svetlana, Dragneva Galina, Laham-Karam Nihay, Honkanen Sanna, Paakinaho Anne, Laakkonen Johanna P, Gao Erhe, Vihinen-Ranta Maija, Liimatainen Timo, Ylä-Herttuala Seppo. 2014. PLoS ONE. 2014 Feb 26;9(2):e89979: e89979 -
Soluble Vascular Endothelial Growth Factor Receptor-1 Improves Therapeutic Efficacy of Suicide Gene Therapy in an Angiogenesis-Independent Manner
Samaranayake Haritha D, Pikkarainen Jere T, Wirth Thomas, Stedt Hanna, Lesch Hanna P, Dragneva Galina, Vuorio Taina, Määttä Ann-Mari, Airenne Kari, Ylä-Herttuala Seppo. 2014. Human gene therapy. 25: 942-954 -
Efficient pro-survival/angiogenic miRNA delivery by an MRI-detectable nanomaterial
Gomes RS, das Neves RP, Cochlin L, Lima A, Carvalho R, Korpisalo P, Dragneva G, Turunen M, Liimatainen T, Clarke K, Ylä-Herttuala S, Carr C, Ferreira L. 2013. Acs nano. : 3362-72 -
Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success
Dragneva G, Korpisalo P, Ylä-Herttuala S. 2013. Disease models and mechanisms. : 312-22